Showing results (161-170 of 282) with videos related to
Sort By:
Pageof 29
Blood|August 8, 2008
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsSusan Branford, Linda Fletcher, Nicholas C P Cross, et al.Blood|January 12, 2012
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBart L Scott, Ted A Gooley, Mohamed L Sorror, et al.Haematologica|May 5, 2022
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemiaKathryn E Flynn, Ehab Atallah, Li Lin, et al.Plos One|August 23, 2013
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemiaEra L Pogosova-Agadjanyan, Kenneth J Kopecky, Fabiana Ostronoff, et al.Blood|August 4, 2010
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Timothy P Hughes, Andreas Hochhaus, Susan Branford, et al.Leukemia Research|February 22, 2018
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasmsTariq I Mughal, Jason Gotlib, Ruben Mesa, et al.JAMA Network Open|December 18, 2023
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid LeukemiaAaron N Winn, Ehab Atallah, Jorge Cortes, et al.Plos One|January 4, 2013
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodiesHema Dave, Miriam R Anver, Donna O Butcher, et al.Investigational New Drugs|December 15, 2015
Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primatesNirali N Shah, Diane E Cole, Cynthia M Lester-McCully, et al.Pediatric Blood & Cancer|October 26, 2017
The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1-Current state of the workforceJeffrey Hord, Mona Shah, Sherif M Badawy, et al.Pageof 29